JP2024547029A5 - - Google Patents

Info

Publication number
JP2024547029A5
JP2024547029A5 JP2024536410A JP2024536410A JP2024547029A5 JP 2024547029 A5 JP2024547029 A5 JP 2024547029A5 JP 2024536410 A JP2024536410 A JP 2024536410A JP 2024536410 A JP2024536410 A JP 2024536410A JP 2024547029 A5 JP2024547029 A5 JP 2024547029A5
Authority
JP
Japan
Prior art keywords
peptide
composition
pain
sequence
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024536410A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024547029A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/086559 external-priority patent/WO2023111348A1/en
Publication of JP2024547029A publication Critical patent/JP2024547029A/ja
Publication of JP2024547029A5 publication Critical patent/JP2024547029A5/ja
Pending legal-status Critical Current

Links

JP2024536410A 2021-12-17 2022-12-19 疼痛の処置における使用のためのペプチド及び方法 Pending JP2024547029A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21306835.6 2021-12-17
EP21306835 2021-12-17
PCT/EP2022/086559 WO2023111348A1 (en) 2021-12-17 2022-12-19 Peptides and methods for use in treating pain

Publications (2)

Publication Number Publication Date
JP2024547029A JP2024547029A (ja) 2024-12-26
JP2024547029A5 true JP2024547029A5 (cg-RX-API-DMAC7.html) 2026-01-06

Family

ID=79317102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024536410A Pending JP2024547029A (ja) 2021-12-17 2022-12-19 疼痛の処置における使用のためのペプチド及び方法

Country Status (12)

Country Link
US (1) US20250051395A1 (cg-RX-API-DMAC7.html)
EP (1) EP4447991A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024547029A (cg-RX-API-DMAC7.html)
KR (1) KR20240126864A (cg-RX-API-DMAC7.html)
CN (1) CN118401249A (cg-RX-API-DMAC7.html)
AR (1) AR129864A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022413983A1 (cg-RX-API-DMAC7.html)
CA (1) CA3239578A1 (cg-RX-API-DMAC7.html)
IL (1) IL313183A (cg-RX-API-DMAC7.html)
MX (1) MX2024007301A (cg-RX-API-DMAC7.html)
TW (1) TW202344689A (cg-RX-API-DMAC7.html)
WO (1) WO2023111348A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026119985A1 (en) * 2024-12-03 2026-06-11 Tafalgie Therapeutics Peptides for use in treating wounds and inflammatory diseases
WO2026119983A1 (en) * 2024-12-03 2026-06-11 Tafalgie Therapeutics Peptides for use in treating pain, wounds and inflammatory diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11514853A (ja) 1995-09-08 1999-12-21 ジエンザイム コーポレイション 遺伝子治療のための改良されたaavベクター
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
WO2006013462A2 (en) * 2004-07-30 2006-02-09 Nsgene A/S Growth factors nsg28, nsg30, and nsg32
EP2801369A1 (en) 2013-05-06 2014-11-12 Centre National De La Recherche Scientifique TAFA4 compounds and uses thereof for treating pain
CN108699604A (zh) 2016-03-08 2018-10-23 艾克斯-马赛大学 用于预测急性疼痛转变为慢性疼痛的myo1a以及myo1a用于治疗疼痛的用途

Similar Documents

Publication Publication Date Title
KR101999756B1 (ko) Cd36 발현을 감소시키는 방법
AU2011218009B2 (en) Treatments for gastrointestinal disorders
US11672841B2 (en) Methods for treating heart disease in a subject with Friedreich's ataxia by an aromatic-cationic peptide
JP4335910B2 (ja) メタスチン誘導体およびその使用
JP2019052157A (ja) 左室リモデリングの予防または治療のための方法
JP6069663B2 (ja) 抗炎症医薬製品
EP3066077A1 (en) Treatment of cardiac remodeling and other heart conditions
US10624944B2 (en) Anti-inflammatory peptides for treating non-alcoholic steatohepatitis (NASH)
US20190022167A1 (en) Methods and compositions for the prevention and treatment of duchenne muscular dystrophy
AU710303B2 (en) Use of insulin-like growth factors (I) and (II) for inhibition of inflammatory response
JP2025519127A5 (cg-RX-API-DMAC7.html)
CN111417647A (zh) 新型senolytic肽
JP4933440B2 (ja) 経皮デリバリーのための薬剤組成物
KR102555817B1 (ko) 당뇨병 및 관련 질환의 치료 및 예방을 위한 펩타이드
US8895503B2 (en) Pharmaceutical composition for transnasal administration of peptide hormones or cytokines
EP4419130B1 (en) Il-4 derived peptides for use in the treatment of obesity
TW201302214A (zh) 治療或預防皮膚癌之類鋅手指胜肽、其表現質體、及包含其之醫藥組成物
EP3536382A1 (en) Prophylactic or therapeutic agent for inflammatory skin disease
JP2023544910A (ja) コロナウイルス治療法
US20240350578A1 (en) Functional outcomes after spinal cord injury
KR102829639B1 (ko) c-Met의 에피토프를 포함하는 암 백신 및 이의 용도
WO2013131879A1 (en) New application for pasireotide
WO2025129029A2 (en) Combinations of foralumab with glucagon-like peptide 1 (glp-1) agonists or sodium-glucose cotransporter-2 (sglt2) inhibitors and methods of use thereof
TW202528339A (zh) 用於治療或預防肝臟病症之骨髓源性生長因子
HK1212718B (en) Methods for reducing cd36 expression